DNLIDenali Therapeutics Inc.
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Rangebound, no clear trend. Price is −6% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Heavily shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How DNLI is trading
Denali Therapeutics Inc. is +53% over the past year while the S&P 500 is +18%: 34 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −5.7%
vs 200-day average · below trend, but not far
- RSI (14)
- 42
RSI (14) · neutral
- Below its 52-week high
- 27%
Below its 52-week high
Details›
- Last close2026-10-09
- $19.46
- 1 monthS&P 500 +2.7%
- −9.1%
- 1 yearS&P 500 +18%
- +53%
- 5 yearsS&P 500 +88%
- −62%
- vs 50-day average$22.41
- −13%
- 52-week high
- $26.48
- 52-week low
- $13.05
- Annualised volatility
- 60%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$108K
| Year | Return |
|---|---|
| 2026 (year to date) | +18% |
| 2025 | −19% |
| 2024 | −5.0% |
| 2023 | −23% |
| 2022 | −38% |
| 2021 | −47% |
| 2020 | +381% |
| 2019 | −16% |
| 2018 | +32% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 9 | 5 of 9 | +6.9% |
| Feb | 9 | 3 of 9 | −2.3% |
| Mar | 9 | 2 of 9 | −8.8% |
| Apr | 9 | 5 of 9 | +0.77% |
| May | 9 | 7 of 9 | +5.6% |
| Jun | 9 | 6 of 9 | +7.3% |
| Jul | 9 | 3 of 9 | −4.4% |
| Aug | 9 | 5 of 9 | +5.8% |
| Sep | 9 | 4 of 9 | +0.51% |
| Oct | 9 | 3 of 9 | −4.0% |
| Nov | 8 | 5 of 8 | +14% |
| Dec | 8 | 3 of 8 | +1.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.